The mean tumor size was 30 mm and 50% of carriers displayed a triple negative breast cancer (TNBC) phenotype with two additional cases harboring negative hormone receptors with unknown human epidermal growth factor receptor 2 (HER2) status. The gene discussed is NR4A1; the disease is neoplasm.